Found 76 matching trials
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC PHASE2 This is a prospective, multi-center, single arm study assessing the efficac...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer PHASE2 Investigators will determine whether a treatment paradigm of up-front neck ...
Show More Location
University of Michigan Cancer Center
Learn More & Join Trial
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors PHASE1 This is a Phase 1 study to assess the safety and clinical activity of RO762...
Show More Location
University of California Irvine Medical Center
Learn More & Join Trial
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma PHASE3 This is a multicenter, randomized, controlled, open-label Phase III clinica...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer PHASE1 The purpose of the study is to compare efficacy of DCVAC/LuCa + chemotherap...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT) PHASE3 This study is a randomized, active-controlled, open-label clinical trial fo...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). PHASE3 This is a randomized, open-label, multi-center, global, Phase III study to ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. PHASE2 This is a study to evaluate the safety and efficacy of EIK1001 administered...
Show More Location
Southern Cancer Center, P.C.
Learn More & Join Trial
Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check) PHASE2 This is an open label, randomized, Phase II multicenter study designed to e...
Show More Location
Asklepios Fachkliniken München-Gauting
Learn More & Join Trial
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC PHASE2 This study is for patients with advanced/metastatic non-small cells lung ca...
Show More Status
Active Not Recruiting
Location
Southern Cancer Care
Learn More & Join Trial